Co-founders of Ripple Biosolutions

"A Tale of Two Startups"

The Raymonds shared their experiences with several different business startups from the somewhat unique perspective of being business as well as life partners. Co-founders of Ripple Biosolutions "A Tale of Two Startups" The Raymonds shared their experiences with several different business startups from the somewhat unique perspective of being business as well as life partners.

Co-Founder and CEO of Recursion

"The Serendipity of Failure: A Journey from Graduate Student to Biotech CEO"

Chris Gibson highlights the serendipity of science and failure, and the role each played in the journey he took from an MD/PhD student to CEO of a multibillion-dollar public biotech company in seven short years.

Fellow at the Center for Law and the Biosciences and Research Fellow of Intellectual Property at Stanford Law School

"Mapping the Worldwide Research, Innovation, and Diffusion Activity of CRISPR"

Samantha Zyontz discussed how CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has profoundly influenced innovation in a range of applications around the world. Her analysis of CRISPR academic articles, patents, companies, and clinical trials highlights an explosion of innovative related activities since the technology’s introduction.

Director and Professor of the Translational Tissue Engineering Center, Johns Hopkins Department of Biomedical Engineering

"Regenerative Immunology – the Role of Technology Translation in Guiding Discovery"

Jennifer Elisseeff discussed regenerative immunology and the role of technology translation in guiding discoveries. She is currently working to understand the role of the immune system and cellular senescence in the biomaterial response and repair across different tissues. This new therapeutic target serves as the basis for the design of regenerative immunotherapies.

Professor Emerit of Biology, University of Oregon’s Institute of Neuroscience; Co-Founder/Chief Global Health Officer, InVivo Biosystems

"From Academic Neuroscience to Co-founding a Biotech Company, via Africa"

An expert in neuroplasticity and infectious and parasitic diseases, Weeks spoke about her journey from academia to biotech.

Anne T. and Robert M. Bass Professor of Chemistry at Stanford University

"Therapeutic Opportunities in Glycoscience"

Carolyn Bertozzi discussed how her research in glycoscience could lead to new therapeutic strategies.

Drosdick Endowed Dean of the College of Engineering, Villanova University

"Start-Up Campus: How to Translate Your Scientific Discovery to a Successful Product"

Michele Marcolongo discussed the roadmap for translating technology to product launch, as well as how to execute the necessary steps to create and launch a start-up company. In addition to her extensive work in academia, Dr. Marcolongo is a successful entrepreneur who has co-founded three biomedical technology startup companies and is a co-holder of 15 patents/patent applications.

Founder and Chief Scientific Officer, Cala Health

“What if Electricity Were a Medicine? An Entrepreneur’s Journey from Scientific Discovery to Category Creation”

Kate Rosenbluth shared the story of founding and building a growth startup from spin-out through product launch. She spun Cala Health out from Stanford on a scientific moonshot to deliver a new class of bioelectronic therapies that use wearable devices to deliver non-invasive neuromodulation for major chronic diseases.